CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA) today announced that it intends to offer and sell $75 million of shares of its common stock in an underwritten public offering. All shares being offered are to be sold by Akebia Therapeutics. As part of the offering, Akebia Therapeutics intends to grant the underwriters a 30-day option to purchase up to an additional $11.25 million of shares of its common stock.
